Daniel Glenn Gibson - 27 Feb 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBIO	Stock Option (right to buy)	Award	$0	+84,700		$0.000000	84,700	27 Feb 2022	Common Stock	84,700	$10.20	Direct	F1, F2
transaction	TBIO	Restricted Stock Unit	Award	$0	+22,100		$0.000000	22,100	27 Feb 2022	Common Stock	22,100		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The exercise price is the closing price of the Issuer's Common stock on February 28, 2022, the first business day following the date of grant.
F2	Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 27, 2022.
F3	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4	Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the remaining RSUs subject to the award shall vest in equal annual installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 27, 2022.